FolioLanternBeta
LLYEli Lilly

Gabrielle Sulzberger

Director at Eli Lilly, as of Sep 22, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
3K
shares held after the latest filing, Eli Lilly
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
4
companies filed for

Last filing: Sep 22, 2026. Most recent purchase on record: Aug 12, 2025.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Eli Lilly (LLY)DirectorNov 17, 2021Sep 22, 2026
Mastercard (MA)DirectorDec 3, 2018Jun 18, 2026
Warby Parker Inc. (WRBY)Former DirectorSep 21, 2021Jun 11, 2024
Teva Pharmaceutical Industries Ltd (TEVA)Former DirectorJan 2, 2018Jan 2, 2018

Also a director at

Mastercard (MA), Warby Parker Inc. (WRBY) (no filing in the last 18 months), Teva Pharmaceutical Industries Ltd (TEVA) (no filing in the last 18 months)

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.